Cargando…
Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073796/ https://www.ncbi.nlm.nih.gov/pubmed/35530962 http://dx.doi.org/10.21037/atm-22-484 |
| _version_ | 1784701365909454848 |
|---|---|
| author | Rozenblit, Mariya Lustberg, Maryam B. |
| author_facet | Rozenblit, Mariya Lustberg, Maryam B. |
| author_sort | Rozenblit, Mariya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9073796 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90737962022-05-07 Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer Rozenblit, Mariya Lustberg, Maryam B. Ann Transl Med Editorial Commentary AME Publishing Company 2022-04 /pmc/articles/PMC9073796/ /pubmed/35530962 http://dx.doi.org/10.21037/atm-22-484 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Rozenblit, Mariya Lustberg, Maryam B. Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| title | Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| title_full | Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| title_fullStr | Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| title_full_unstemmed | Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| title_short | Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| title_sort | sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073796/ https://www.ncbi.nlm.nih.gov/pubmed/35530962 http://dx.doi.org/10.21037/atm-22-484 |
| work_keys_str_mv | AT rozenblitmariya sacituzumabgovitecanascendingthetreatmentalgorithmintriplenegativebreastcancer AT lustbergmaryamb sacituzumabgovitecanascendingthetreatmentalgorithmintriplenegativebreastcancer |